This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Schuette, S. A. Articles by Janghorbani, M. Search for Related Content PubMed PubMed Citation Articles by Schuette, S. A. Articles by Janghorbani, M. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB GLYCINE MAGNESIUM COMPOUNDS MAGNESIUM, ELEMENTAL MAGNESIUM OXIDE Social Bookmarking                         What's this?

Bioavailability of Magnesium Diglycinate vs Magnesium Oxide in Patients with Ileal Resection

University of Chicago, Department of Medicine, Section of Gastroenterology, BioChemAnalysis Corp, 2201 West Campbell Park Drive, Chicago IL 60612

Bret A. Lashner, MD

University of Chicago, Department of Medicine, Section of Gastroenterology, Department of Gastroenterology, Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Morteza Janghorbani, PHD

University of Chicago, Department of Medicine, Section of Gastroenterology, BioChemAnalysis Corp, 2201 West Campbell Park Drive, Chicago IL 60612

Background: Patients who have undergone ileal resection are at risk for developing magnesium depletion/deficiency because of poor absorption and decreased intake as well as increased endogenous losses. Magnesium repletion is difficult to accomplish because of the cathartic action of most oral magnesium supplements at therapeutic doses. The results of in vitro and in situ studies show that magnesium diglycinate (chelate) represents a highly available form of magnesium that is absorbed in part as an intact dipeptide in the proximal small intestine. Methods: We conducted a double-blind, randomized crossover trial with 12 patients who had ileal resections in order to compare the bioavailability of a 100-mg dose of ²⁶Mg-labeled chelate with MgO in this patient population. Results: For the patient group as a whole, ²⁶Mg absorption was low but was not different for the two supplements (23.5% vs 22.8% for magnesium chelate and MgO, respectively). However, ²⁶Mg absorption was substantially greater from the chelate (23.5% vs 11.8%; p < .05) in the four patients who showed the greatest impairment of magnesium absorption with MgO and was better tolerated by all patients. Peak isotope enrichment also occurred significantly earlier after ²⁶Mg chelate than after ²⁶MgO ingestion (mean difference 3.2 ± 1.3 hours; p < .05), and the area under the enrichment vs time curve was greater after chelate ingestion (p < .05). Conclusions: Data from this study support the suggestion that some portion of magnesium diglycinate is absorbed intact, probably via a dipeptide transport pathway. Magnesium diglycinate may be a good alternative to commonly used magnesium supplements in patients with intestinal resection. (Journal of Parenteral and Enteral Nutrition 18:430-435, 1994)

Journal of Parenteral and Enteral Nutrition, Vol. 18, No. 5, 430-435 (1994)
DOI: 10.1177/0148607194018005430


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				M. Sabatier, W. R Keyes, F. Pont, M. J Arnaud, and J. R Turnlund Comparison of stable-isotope-tracer methods for the determination of magnesium absorption in humans Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1206 - 1212. [Abstract] [Full Text] [PDF]

				S. A. Abrams and J.-P. Wen Methodologies for Using Stable Isotopes to Assess Magnesium Absorption and Secretion in Children J. Am. Coll. Nutr., February 1, 1999; 18(1): 30 - 35. [Abstract] [Full Text] [PDF]